Mikhail Chernov

Roswell Park Comprehensive Cancer Center — United States

Medicine · Health Sciences

7h-index499citations25works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hormonal Regulation and Hypertension(4), Estrogen and related hormone effects(3), Vitamin D Research Studies(2), Angiogenesis and VEGF in Cancer(2), Cancer, Hypoxia, and Metabolism(2)

Publications25 total

Identification of TAZ-Dependent Breast Cancer Vulnerabilities Using a Chemical Genomics Screening Approach
Frontiers in Cell and Developmental Biology·2021· 9 citedOpen Access
Abstract LT015: Overcoming chemotherapy resistance in triple negative breast cancer <i>via</i> targeting lysyl oxidase (LOX)
Cancer Research·2021· 2 cited
NTRK1 is a positive regulator of YAP oncogenic function
Oncogene·2018· 27 citedOpen Access
Abstract 1178: Unbiased efficacy-based screening of small molecules highly selective against hematological malignancies revealed inhibitor of NAD synthesis
Cancer Research·2017
Abstract 866: Delineation of novel CYP24A1 transcriptional regulators
Cancer Research·2016
JFQ volume 51 issue 3 Cover and Front matter
Journal of Financial and Quantitative Analysis·2016· 1 citedOpen Access
JFQ volume 51 issue 2 Cover and Front matter
Journal of Financial and Quantitative Analysis·2016Open Access
JFQ volume 51 issue 1 Cover and Front matter
Journal of Financial and Quantitative Analysis·2016· 1 citedOpen Access
JFQ volume 50 issue 6 Cover and Front matter
Journal of Financial and Quantitative Analysis·2015Open Access
JFQ volume 50 issue 5 Cover and Front matter
Journal of Financial and Quantitative Analysis·2015Open Access
JFQ volume 50 issue 4 Cover and Front matter
Journal of Financial and Quantitative Analysis·2015Open Access
Arginylation regulates purine nucleotide biosynthesis by enhancing the activity of phosphoribosyl pyrophosphate synthase
Nature Communications·2015· 50 citedOpen Access
Abstract B3: Anti-angiogenic properties of FAK-VEGFR3 scaffold inhibitors, C9 and C10.
Molecular Cancer Therapeutics·2013
JFQ volume 48 issue 2 Cover and Front matter
Journal of Financial and Quantitative Analysis·2013Open Access
Abstract 1819: Over-expression of PIM1 kinase contributes to CYP24A1 gene up-regulation in prostate cancer.
Cancer Research·2013
Inhibition of Protein Kinase CK2 Reduces <i>Cyp24a1</i> Expression and Enhances 1,25-Dihydroxyvitamin D3 Antitumor Activity in Human Prostate Cancer Cells
Cancer Research·2013· 36 citedOpen Access
JFQ volume 47 issue 5 Cover and Front matter
Journal of Financial and Quantitative Analysis·2012Open Access
Influence of social adaptation of tuberculosis patients on the TB form and a chemotherapy outcomes
2012
Small molecule inhibitors of arginyltransferase regulate arginylation-dependent protein degradation, cell motility, and angiogenesis
Biochemical Pharmacology·2012· 44 citedOpen Access
JFQ volume 46 issue 6 Cover and Front matter
Journal of Financial and Quantitative Analysis·2011Open Access
page 1 of 2Next →

Frequent Co-authors

Mark Grinblatt(11), Warren Bailey(11), Gurdip Bakshi(11), Murillo Campello(11), Jeffrey L. Coles(11), Wayne E. Ferson(11), Jonathan M. Karpoff(11), Francis A. Longstaff(11), Ronald W. Masulis(11), John J. McConnell(11), Neil D. Pearson(11), George Pennacchi(11), Jeffrey Pontiff(11), Jay R. Ritter(11), Sergei Sarkissian(11), Paul Schultz(11), Michael S. Foster(11), Alex Edmans(8), Darius Palia(8), Chester Kumar(8)